title: Antidiabetic treatment: Though lovers be lost, love shall not.
abstract: The new position statement of the American Diabetes Association and the European Association for the Study of Diabetes on the management of type 2 diabetes mellitus represents a paradigm shift in our understanding of antidiabetic treatment. It emphasises the necessity to individualise management based on patient needs. Glycaemic targets should also be pursued on an individualised basis. New therapeutic combinations are discussed, and the uncertainty surrounding the ideal choice is acknowledged. Above all, it is the mindful and experienced clinician who will implement the best available evidence towards flexible and efficacious treatment. Some areas of uncertainty may ensue, but it is expected that the new position statement will improve patient healthcare and treatment satisfaction. This now remains to be seen in practice.
authors.affiliation: Nikolaos Papanas, Efstratios Maltezos, Outpatient Clinic of Obesity, Diabetes and Metabolism, Second Department of Internal Medicine, Democritus University of Thrace, Alexandroupolis 68100, Greece.
authors.forename: Nikolaos
authors.initials: N
authors.lastname: Papanas
authors.forename: Efstratios
authors.initials: E
authors.lastname: Maltezos
keywords: Diabetes mellitus; Guidelines; Insulin; Oral agents; Treatment